{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:43:39Z","timestamp":1792806219694,"version":"4.5.0"},"reference-count":266,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.autrev.2020.102740","type":"journal-article","created":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T06:09:08Z","timestamp":1608098948000},"page":"102740","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Rheumatic heart disease: A review of the current status of global research activity"],"prefix":"10.1016","volume":"20","author":[{"given":"Leanne M.","family":"Dooley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek B.","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Good","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kotiw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2020.102740_bb0005","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S1473-3099(04)00975-2","article-title":"Acute rheumatic fever: a chink in the chain that links the heart to the throat?","volume":"4","author":"McDonald","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.autrev.2020.102740_bb0010","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/infdis\/jix637","article-title":"Group G Streptococcus induces an autoimmune carditis mediated by interleukin 17A and interferon gamma in the Lewis rat model of rheumatic heart disease","volume":"218","author":"Sikder","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.autrev.2020.102740_bb0015","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1086\/322665","article-title":"Rheumatic fever in the 21st century","volume":"33","author":"Stollerman","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.autrev.2020.102740_bb0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1161\/01.CIR.48.1.9","article-title":"The chain that links the heart to the throat","volume":"48","author":"Wannamaker","year":"1973","journal-title":"Circulation."},{"key":"10.1016\/j.autrev.2020.102740_bb0025","doi-asserted-by":"crossref","first-page":"201","DOI":"10.5694\/mja16.00400","article-title":"The inequitable burden of group A streptococcal diseases in Indigenous Australians: we need to fill evidence gaps and make clinical advances to reduce these diseases of disadvantage","volume":"205","author":"May","year":"2016","journal-title":"Med J Aust"},{"key":"10.1016\/j.autrev.2020.102740_bb0030","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.hlc.2007.02.087","article-title":"Apparent contrasting rates of pharyngitis and pyoderma in regions where rheumatic heart disease is highly prevalent","volume":"16","author":"McDonald","year":"2007","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.autrev.2020.102740_bb0035","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1086\/506938","article-title":"Low rates of streptococcal pharyngitis and high rates of pyoderma in Australian Aboriginal communities where acute rheumatic fever is hyperendemic","volume":"43","author":"McDonald","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.autrev.2020.102740_bb0040","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1440-1754.2010.01841.x","article-title":"Rheumatic fever in Indigenous Australian children","volume":"46","author":"Parnaby","year":"2010","journal-title":"Paediatr Child Health"},{"key":"10.1016\/j.autrev.2020.102740_bb0045","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.tim.2010.02.007","article-title":"The streptococcal M protein: a highly versatile molecule","volume":"18","author":"Smeesters","year":"2010","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.autrev.2020.102740_bb0050","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/infdis\/jiu260","article-title":"A systematic and functional classification of Streptococcus pyogenes that serves as a new tool for molecular typing and vaccine development","volume":"210","author":"Sanderson-Smith","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.autrev.2020.102740_bb0055","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1473-3099(09)70178-1","article-title":"Global emm type distribution of group A streptococci: systematic review and implications for vaccine development","volume":"9","author":"Steer","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.autrev.2020.102740_bb0060","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1080\/21645515.2018.1462427","article-title":"Contribution of cryptic epitopes in designing a group A streptococcal vaccine","volume":"14","author":"Ozberk","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.autrev.2020.102740_bb0065","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.micinf.2017.12.009","article-title":"Cellular interactions of CovR\/S mutant group A Streptococci","volume":"20","author":"Langshaw","year":"2018","journal-title":"Microbes Infect"},{"key":"10.1016\/j.autrev.2020.102740_bb0070","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jaut.2018.10.012","article-title":"Molecular mimicry and autoimmunity","volume":"95","author":"Rojas","year":"2018","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2020.102740_bb0075","series-title":"Gram-Positive Pathogens","first-page":"86","article-title":"Molecular mimicry, autoimmunity, and infection: the cross-reactive antigens of group A Streptococci and their sequelae","author":"Cunningham","year":"2019"},{"key":"10.1016\/j.autrev.2020.102740_bb0080","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1161\/CIRCULATIONAHA.108.792135","article-title":"Some of the people, some of the time: susceptibility to acute rheumatic fever","volume":"119","author":"Bryant","year":"2009","journal-title":"Circulation."},{"key":"10.1016\/j.autrev.2020.102740_bb0085","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4103\/0974-2069.79617","article-title":"Genes, autoimmunity and pathogenesis of rheumatic heart disease","volume":"4","author":"Guilherme","year":"2011","journal-title":"Ann Pediatr Cardiol"},{"key":"10.1016\/j.autrev.2020.102740_bb0090","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1093\/infdis\/jix497","article-title":"Genome-wide analysis of genetic risk factors for rheumatic heart disease in Aboriginal Australians provides support for pathogenic molecular mimicry","volume":"216","author":"Gray","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.autrev.2020.102740_bb0095","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41569-019-0258-2","article-title":"Genetics of rheumatic fever and rheumatic heart disease","volume":"17","author":"Muhamed","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.autrev.2020.102740_bb0100","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10875-009-9332-6","article-title":"Rheumatic fever and rheumatic heart disease: cellular mechanisms leading autoimmune reactivity and disease","volume":"30","author":"Guilherme","year":"2010","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2020.102740_bb0105","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jama.1944.02850430015005","article-title":"The diagnosis of rheumatic fever","volume":"126","author":"Jones","year":"1944","journal-title":"JAMA."},{"key":"10.1016\/j.autrev.2020.102740_bb0110","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S1568-9972(02)00062-9","article-title":"Rheumatic fever: the T cell response leading to autoimmune aggression in the heart","volume":"1","author":"Guilherme","year":"2002","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102740_bb0115","first-page":"256","article-title":"Aschoff bodies of rheumatic carditis are granulomatous lesions of histiocytic origin","volume":"1","author":"Love","year":"1988","journal-title":"Mod Pathol"},{"key":"10.1016\/j.autrev.2020.102740_bb0120","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1128\/CMR.13.3.470","article-title":"Pathogenesis of group A streptococcal infections","volume":"13","author":"Cunningham","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.autrev.2020.102740_bb0125","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1056\/NEJMoa1603693","article-title":"Global, regional, and national burden of rheumatic heart disease, 1990-2015","volume":"377","author":"Watkins","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2020.102740_bb0130","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","article-title":"The global burden of group A streptococcal diseases","volume":"5","author":"Carapetis","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.autrev.2020.102740_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006577","article-title":"The role of social determinants of health in the risk and prevention of group A streptococcal infection, acute rheumatic fever and rheumatic heart disease: a systematic review","volume":"12","author":"Coffey","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.autrev.2020.102740_bb0140","author":"World Health Organisation"},{"key":"10.1016\/j.autrev.2020.102740_bb0145","unstructured":"RHDAustralia and M. McDonald. Fast Facts Flyer, https:\/\/www.rhdaustralia.org.au\/resources\/fast-facts-flyer; 2018 [accessed 30 June 2019]."},{"key":"10.1016\/j.autrev.2020.102740_bb0150","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001282","article-title":"Disparity in mortality from rheumatic heart disease in Indigenous Australians","volume":"4","author":"Colquhoun","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.autrev.2020.102740_bb0155","doi-asserted-by":"crossref","unstructured":"Wyber RJ, Cannon J, Katzenellenbogen J. Telethon Kids Institute. The cost of inaction on rheumatic heart disease: the predicted human and financial costs of rheumatic heart disease for Aboriginal and Torres Strait Islander people 2016-2031, https:\/\/endrhd.telethonkids.org.au\/SysSiteAssets\/media-docs---end-rhd\/cost-of-inaction-on-rheumatic-heart-disease_edited.pdf; 2018 [accessed 30 June 2019].","DOI":"10.1016\/j.hlc.2019.05.130"},{"key":"10.1016\/j.autrev.2020.102740_bb0160","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.3390\/ijerph16224515","article-title":"Risk factors for acute rheumatic fever: literature review and protocol for a case-control study in New Zealand","volume":"16","author":"Baker","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.autrev.2020.102740_bb0165","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/jpids\/piu030","article-title":"The group A streptococcal carrier state reviewed: still an enigma","volume":"3","author":"DeMuri","year":"2014","journal-title":"J Pediat Inf Dis Soc"},{"key":"10.1016\/j.autrev.2020.102740_bb0170","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2431-12-3","article-title":"Detection of group A Streptococcus in tonsils from pediatric patients reveals high rate of asymptomatic streptococcal carriage","volume":"12","author":"Roberts","year":"2012","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.autrev.2020.102740_bb0175","doi-asserted-by":"crossref","first-page":"e557","DOI":"10.1542\/peds.2009-2648","article-title":"Prevalence of streptococcal pharyngitis and streptococcal carriage in children: a meta-analysis","volume":"126","author":"Shaikh","year":"2010","journal-title":"Pediatrics."},{"key":"10.1016\/j.autrev.2020.102740_bb0180","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1084\/jem.57.4.571","article-title":"A serological differentiation of human and other groups of hemolytic streptococci","volume":"57","author":"Lancefield","year":"1933","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2020.102740_bb0185","series-title":"Streptococcus Pyogenes: Basic Biology to Clinical Manifestations","article-title":"Severe group A streptococcal infections","author":"Stevens","year":"2016"},{"key":"10.1016\/j.autrev.2020.102740_bb0190","doi-asserted-by":"crossref","first-page":"4658","DOI":"10.1073\/pnas.071559398","article-title":"Complete genome sequence of an M1 strain of Streptococcus pyogenes","volume":"98","author":"Ferretti","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2020.102740_bb0195","series-title":"Streptococcus Pyogenes: Basic Biology to Clinical Manifestations","article-title":"Streptococcal Superantigens: Biological properties and potential role in disease","author":"Proft","year":"2016"},{"key":"10.1016\/j.autrev.2020.102740_bb0200","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.tim.2007.05.001","article-title":"New understanding of the group A Streptococcus pathogenesis cycle","volume":"15","author":"Tart","year":"2007","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.autrev.2020.102740_bb0205","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/00005537-199705000-00016","article-title":"Intracellular reservoir of Streptococcus pyogenes in vivo: a possible explanation for recurrent pharyngotonsillitis","volume":"107","author":"Osterlund","year":"1997","journal-title":"Laryngoscope."},{"key":"10.1016\/j.autrev.2020.102740_bb0210","doi-asserted-by":"crossref","first-page":"5376","DOI":"10.1128\/IAI.71.9.5376-5380.2003","article-title":"Intracellular survival of Streptococcus pyogenes in polymorphonuclear cells results in increased bacterial virulence","volume":"71","author":"Medina","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.autrev.2020.102740_bb0215","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01690-14","article-title":"Streptolysin O and NAD-glycohydrolase prevent phagolysosome acidification and promote group A Streptococcus survival in macrophages","volume":"5","author":"Bastiat-Sempe","year":"2014","journal-title":"MBio."},{"key":"10.1016\/j.autrev.2020.102740_bb0220","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00661-16","article-title":"One more disguise in the stealth behavior of Streptococcus pyogenes","volume":"7","author":"Fischetti","year":"2016","journal-title":"MBio."},{"key":"10.1016\/j.autrev.2020.102740_bb0225","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1128\/CMR.2.3.285","article-title":"Streptococcal M protein: molecular design and biological behavior","volume":"2","author":"Fischetti","year":"1989","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.autrev.2020.102740_bb0230","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1084\/jem.47.1.91","article-title":"The antigenic complex of Streptococcus haemolyticus\u202f: I. demonstration of a type-specific substance in extracts of Streptococcus haemolyticus","volume":"47","author":"Lancefield","year":"1928","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2020.102740_bb0235","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1365-2958.2005.04913.x","article-title":"Binding of human plasma proteins to Streptococcus pyogenes M protein determines the location of opsonic and non-opsonic epitopes","volume":"59","author":"Sandin","year":"2006","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.autrev.2020.102740_bb0240","doi-asserted-by":"crossref","first-page":"43039","DOI":"10.1038\/srep43039","article-title":"Group A streptococcal M1 protein provides resistance against the antimicrobial activity of histones","volume":"7","author":"Dohrmann","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2020.102740_bb0245","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.GPP3-0012-2018","article-title":"Surface proteins on Gram-positive bacteria","volume":"7","author":"Fischetti","year":"2019","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.autrev.2020.102740_bb0250","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1440-1754.2007.01051.x","article-title":"Group A streptococcal infections in children","volume":"43","author":"Steer","year":"2007","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.autrev.2020.102740_bb0255","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1086\/506944","article-title":"Antecedent streptococcal infection in acute rheumatic fever","volume":"43","author":"Kaplan","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.autrev.2020.102740_bb0260","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/QCO.0b013e3283511d27","article-title":"Streptococcal skin infection and rheumatic heart disease","volume":"25","author":"Parks","year":"2012","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.autrev.2020.102740_bb0265","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(00)02765-3","article-title":"Pharyngeal carriage of group C and group G Streptococci and acute rheumatic fever in an Aboriginal population","volume":"356","author":"Haidan","year":"2000","journal-title":"Lancet."},{"key":"10.1016\/j.autrev.2020.102740_bb0270","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/infdis\/jiy560","article-title":"Caution indicated in extrapolating carditis in rats to rheumatic heart disease in humans","volume":"219","author":"Dale","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.autrev.2020.102740_bb0275","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1097\/INF.0000000000001558","article-title":"Acute rheumatic fever after group A Streptococcus pyoderma and group G Streptococcus pharyngitis","volume":"36","author":"O\u2019Sullivan","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.autrev.2020.102740_bb0280","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fped.2015.00091","article-title":"Editorial: Frontiers in autoimmune disease: rheumatic fever and rheumatic heart disease","volume":"3","author":"Guilherme","year":"2015","journal-title":"Front Pediatr"},{"key":"10.1016\/j.autrev.2020.102740_bb0285","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3389\/fped.2014.00148","article-title":"The lectin pathway of complement and rheumatic heart disease","volume":"2","author":"Beltrame","year":"2015","journal-title":"Front Pediatr"},{"key":"10.1016\/j.autrev.2020.102740_bb0290","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1111\/j.1462-5822.2007.00981.x","article-title":"Macrophage complement receptors and pathogen clearance","volume":"9","author":"Van Lookeren","year":"2007","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.autrev.2020.102740_bb0295","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1161\/CIRCULATIONAHA.118.033891","article-title":"Dysregulated IL-1\u03b2-GM-CSF axis in acute rheumatic fever that is limited by hydroxychloroquine","volume":"138","author":"Kim","year":"2018","journal-title":"Circulation."},{"key":"10.1016\/j.autrev.2020.102740_bb0300","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1080\/00365540310016259","article-title":"Proinflammatory activity of cell-wall constituents from Gram-positive bacteria","volume":"35","author":"Moreillon","year":"2003","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.autrev.2020.102740_bb0305","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.4049\/jimmunol.1403173","article-title":"TLR8 senses bacterial RNA in human monocytes and plays a nonredundant role for recognition of Streptococcus pyogenes","volume":"195","author":"Eigenbrod","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2020.102740_bb0310","first-page":"1","article-title":"Ficolins and the recognition of pathogenic microorganisms: an overview of the innate immune response and contribution of single nucleotide polymorphisms. J","volume":"1","author":"Bidula","year":"2019","journal-title":"Immunol Res"},{"key":"10.1016\/j.autrev.2020.102740_bb0315","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12250-014-3421-2","article-title":"Ficolins and infectious diseases","volume":"29","author":"Ren","year":"2014","journal-title":"Virol Sin"},{"key":"10.1016\/j.autrev.2020.102740_bb0320","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s12026-017-8978-z","article-title":"T cell subsets: an integral component in pathogenesis of rheumatic heart disease","volume":"66","author":"Toor","year":"2018","journal-title":"Immunol Res"},{"key":"10.1016\/j.autrev.2020.102740_bb0325","doi-asserted-by":"crossref","first-page":"5937","DOI":"10.1073\/pnas.0904831107","article-title":"Induction of TGF-beta1 and TGF-beta1-dependent predominant Th17 differentiation by group A streptococcal infection","volume":"107","author":"Wang","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2020.102740_bb0330","doi-asserted-by":"crossref","first-page":"581","DOI":"10.3389\/fimmu.2015.00581","article-title":"Streptolysin O rapidly impairs neutrophil oxidative burst and antibacterial responses to group A streptococcus","volume":"6","author":"Uchiyama","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2020.102740_bb0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101464","article-title":"The innate immune response elicited by group A Streptococcus is highly variable among clinical isolates and correlates with the emm type","volume":"9","author":"Dinis","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2020.102740_bb0340","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1086\/650167","article-title":"The human immune response to streptococcal extracellular antigens: clinical, diagnostic, and potential pathogenetic implications","volume":"50","author":"Johnson","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.autrev.2020.102740_bb0345","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0140-6736(94)92083-4","article-title":"Towards a vaccine for rheumatic fever: identification of a conserved target epitope on M protein of group A streptococci","volume":"344","author":"Pruksakorn","year":"1994","journal-title":"Lancet."},{"key":"10.1016\/j.autrev.2020.102740_bb0350","first-page":"ciaa044","article-title":"Naturally-acquired protection against upper respiratory symptoms involving group A Streptococcus in a longitudinal cohort study","author":"Lewnard","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.autrev.2020.102740_bb0355","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/infdis\/jiz615","article-title":"Longitudinal analysis of group A Streptococcus emm types and emm clusters in a high prevalence setting reveals past infection does not prevent future infection","volume":"221","author":"Campbell","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.autrev.2020.102740_bb0360","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.4049\/jimmunol.1500804","article-title":"Adaptive immunity against streptococcus pyogenes in adults involves increased IFN-gamma and IgG3 responses compared with children","volume":"195","author":"Mortensen","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2020.102740_bb0365","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.4049\/jimmunol.161.4.2020","article-title":"Molecular analysis of polyreactive monoclonal antibodies from rheumatic carditis: human anti-N-acetylglucosamine\/anti-myosin antibody V region genes","volume":"161","author":"Adderson","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2020.102740_bb0370","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/infdis\/162.4.875","article-title":"A new heart-cross-reactive antigen in Streptococcus pyogenes is not M protein","volume":"162","author":"Barnett","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1016\/j.autrev.2020.102740_bb0375","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1128\/iai.62.6.2440-2449.1994","article-title":"Cloning and sequence analysis of a gene encoding a 67-kilodalton myosin-cross-reactive antigen of Streptococcus pyogenes reveals its similarity with class II major histocompatibility antigens","volume":"62","author":"Kil","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.autrev.2020.102740_bb0380","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1172\/JCI7132","article-title":"Cytotoxic mAb from rheumatic carditis recognizes heart valves and laminin","volume":"106","author":"Galvin","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2020.102740_bb0385","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/cei.12135","article-title":"Streptococcal-vimentin cross-reactive antibodies induce microvascular cardiac endothelial proinflammatory phenotype in rheumatic heart disease","volume":"173","author":"Delunardo","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2020.102740_bb0390","doi-asserted-by":"crossref","first-page":"5524","DOI":"10.4049\/jimmunol.1102592","article-title":"Brain human monoclonal autoantibody from sydenham chorea targets dopaminergic neurons in transgenic mice and signals dopamine D2 receptor: implications in human disease","volume":"191","author":"Cox","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2020.102740_bb0395","doi-asserted-by":"crossref","first-page":"7412","DOI":"10.4049\/jimmunol.178.11.7412","article-title":"Tubulin is a neuronal target of autoantibodies in Sydenham\u2019s chorea","volume":"178","author":"Kirvan","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2020.102740_bb0400","first-page":"118","article-title":"\u03b1-helical coiled-coil molecules: a role in autoimmunity against the heart","volume":"68","author":"Cunningham","year":"1993","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2020.102740_bb0405","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1128\/iai.65.9.3913-3923.1997","article-title":"Molecular analysis of human cardiac myosin-cross-reactive B- and T-cell epitopes of the group A streptococcal M5 protein","volume":"65","author":"Cunningham","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.autrev.2020.102740_bb0410","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1128\/IAI.01514-08","article-title":"B- and T-Cell responses in group A Streptococcus M-protein- or peptide-induced experimental carditis","volume":"77","author":"Gorton","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.autrev.2020.102740_bb0415","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1086\/318076","article-title":"Pathogenic mechanisms in rheumatic carditis: focus on valvular endothelium","volume":"183","author":"Roberts","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.autrev.2020.102740_bb0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fped.2014.00085","article-title":"Rethinking molecular mimicry in rheumatic heart disease and autoimmune myocarditis: laminin, collagen IV, CAR, and B1AR as initial targets of disease","volume":"2","author":"Root-Bernstein","year":"2014","journal-title":"Front Pediatr"},{"key":"10.1016\/j.autrev.2020.102740_bb0425","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1128\/CMR.19.1.80-94.2006","article-title":"Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease","volume":"19","author":"Fujinami","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.autrev.2020.102740_bb0430","first-page":"88","article-title":"P King, et al. Aberrant expression of HLA-DR antigen on valvular fibroblasts from patients with active rheumatic carditis","volume":"66","author":"Amoils","year":"1986","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2020.102740_bb0435","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0046-8177(85)80227-6","article-title":"Monoclonal antibody identification of mononuclear cells in endomyocardial biopsy specimens from a patient with rheumatic carditis","volume":"16","author":"Marboe","year":"1985","journal-title":"Hum Pathol"},{"key":"10.1016\/j.autrev.2020.102740_bb0440","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.micinf.2012.07.003","article-title":"Immune responsiveness during disease progression from acute rheumatic fever to chronic rheumatic heart disease","volume":"14","author":"Toor","year":"2012","journal-title":"Microbes Infect"},{"key":"10.1016\/j.autrev.2020.102740_bb0445","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s11882-014-0491-z","article-title":"Autoimmune valvular carditis","volume":"15","author":"Breed","year":"2015","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.autrev.2020.102740_bb0450","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1007\/s10753-013-9606-2","article-title":"CXCL9\/Mig mediates T cells recruitment to valvular tissue lesions of chronic rheumatic heart disease patients","volume":"36","author":"Fa\u00e9","year":"2013","journal-title":"Inflammation."},{"key":"10.1016\/j.autrev.2020.102740_bb0455","doi-asserted-by":"crossref","first-page":"78","DOI":"10.2310\/JIM.0000000000000023","article-title":"A shift in the balance of regulatory T and T helper 17 cells in rheumatic heart disease","volume":"62","author":"Bas","year":"2014","journal-title":"J Invest Med"},{"key":"10.1016\/j.autrev.2020.102740_bb0460","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jaut.2005.01.007","article-title":"How an autoimmune reaction triggered by molecular mimicry between streptococcal M protein and cardiac tissue proteins leads to heart lesions in rheumatic heart disease","volume":"24","author":"Fa\u00e9","year":"2005","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2020.102740_bb0465","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1196\/annals.1361.054","article-title":"Rheumatic fever: how S. pyogenes-primed peripheral T cells trigger heart valve lesions","volume":"1051","author":"Guilherme","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2020.102740_bb0470","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1086\/318076","article-title":"Pathogenic mechanisms in rheumatic carditis: focus on valvular endothelium","volume":"183","author":"Roberts","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.autrev.2020.102740_bb0475","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/ard.22.3.127","article-title":"Origin of the Aschoff body","volume":"22","author":"Wedum","year":"1963","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102740_bb0480","first-page":"467","article-title":"Studies on the myocardial Aschoff Body: I. descriptive classification of lesions","volume":"10","author":"Gross","year":"1934","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2020.102740_bb0485","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1161\/CIRCULATIONAHA.104.473165","article-title":"Calcified rheumatic valve neoangiogenesis is associated with vascular endothelial growth factor expression and osteoblast-like bone formation","volume":"111","author":"Rajamannan","year":"2005","journal-title":"Circulation."},{"key":"10.1016\/j.autrev.2020.102740_bb0490","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1749-6632.2009.04653.x","article-title":"Autoantigens identified by screening a human heart cDNA library with acute rheumatic fever sera","volume":"1173","author":"Towers","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2020.102740_bb0495","doi-asserted-by":"crossref","first-page":"15084","DOI":"10.1038\/nrdp.2015.84","article-title":"Acute rheumatic fever and rheumatic heart disease","volume":"2","author":"Carapetis","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.autrev.2020.102740_bb0500","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1017\/S0022172400038377","article-title":"Heredity, infection and chemoprophylaxis in rheumatic carditis: an epidemiological study of a communal settlement","volume":"58","author":"Davies","year":"2009","journal-title":"J Hyg (Lond)"},{"key":"10.1016\/j.autrev.2020.102740_bb0505","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0140-6736(01)90541-0","article-title":"Barbeian Lectures on the various manifestations of the rheumatic state as exemplified in childhood and early life","volume":"133","author":"Cheadle","year":"1889","journal-title":"Lancet."},{"key":"10.1016\/j.autrev.2020.102740_bb0510","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025326","article-title":"Genetic susceptibility to acute rheumatic fever: a systematic review and meta-analysis of twin studies","volume":"6","author":"Engel","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2020.102740_bb0515","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1128\/IAI.01152-13","article-title":"Susceptibility to acute rheumatic fever based on differential expression of genes involved in cytotoxicity, chemotaxis, and apoptosis","volume":"82","author":"Bryant","year":"2014","journal-title":"Infect Immun"},{"key":"10.1016\/j.autrev.2020.102740_bb0520","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3389\/fimmu.2013.00352","article-title":"Rheumatic heart disease: molecules involved in valve tissue inflammation leading to the autoimmune process and anti-S. pyogenes vaccine","volume":"4","author":"Guilherme","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2020.102740_bb0525","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2249.2009.03975.x","article-title":"Ficolin 2 (FCN2) functional polymorphisms and the risk of rheumatic fever and rheumatic heart disease","volume":"157","author":"Messias-Reason","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2020.102740_bb0530","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.humimm.2014.10.003","article-title":"Association of MASP2 polymorphisms and protein levels with rheumatic fever and rheumatic heart disease","volume":"75","author":"Catarino","year":"2014","journal-title":"Hum Immunol"},{"key":"10.1016\/j.autrev.2020.102740_bb0535","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00109-005-0677-x","article-title":"TLR-2 gene Arg753Gln polymorphism is strongly associated with acute rheumatic fever in children","volume":"83","author":"Berdeli","year":"2005","journal-title":"J Mol Med"},{"key":"10.1016\/j.autrev.2020.102740_bb0540","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s10067-009-1252-6","article-title":"No association of the TLR2 gene Arg753Gln polymorphism with rheumatic heart disease and Behcet\u2019s disease","volume":"28","author":"Co\u015fan","year":"2009","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2020.102740_bb0545","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1177\/0004563214564581","article-title":"A normal polymorphism site of TLR2 3\u2032 untranslated region is related to rheumatic heart disease by up-regulating TLR2 expression","volume":"52","author":"Li","year":"2014","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.autrev.2020.102740_bb0550","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1161\/01.CIR.83.6.1995","article-title":"Association of human leukocyte class II antigens with rheumatic fever or rheumatic heart disease in a Brazilian population","volume":"83","author":"Guilherme","year":"1991","journal-title":"Circulation."},{"key":"10.1016\/j.autrev.2020.102740_bb0555","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1172\/JCI114071","article-title":"Presence of a non-HLA B cell antigen in rheumatic fever patients and their families as defined by a monoclonal antibody","volume":"83","author":"Khanna","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2020.102740_bb0560","doi-asserted-by":"crossref","first-page":"507","DOI":"10.5694\/j.1326-5377.2006.tb00345.x","article-title":"B-cell antigen D8\/17 is a marker of rheumatic fever susceptibility in Aboriginal Australians and can be tested in remote settings","volume":"184","author":"Harrington","year":"2006","journal-title":"Med J Australia"},{"key":"10.1016\/j.autrev.2020.102740_bb0565","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1034\/j.1399-0004.2002.610409.x","article-title":"Presence of the d8\/17 B-cell marker in children with rheumatic fever in Israel","volume":"61","author":"Harel","year":"2002","journal-title":"Clin Genet"},{"key":"10.1016\/j.autrev.2020.102740_bb0570","doi-asserted-by":"crossref","first-page":"14946","DOI":"10.1038\/ncomms14946","article-title":"Association between a common immunoglobulin heavy chain allele and rheumatic heart disease risk in Oceania","volume":"8","author":"Parks","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2020.102740_bb0575","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.cyto.2012.10.020","article-title":"A study on the association of TNF-alpha(-308), IL-6(-174), IL-10(-1082) and IL-1Ra(VNTR) gene polymorphisms with rheumatic heart disease in Pakistani patients","volume":"61","author":"Rehman","year":"2013","journal-title":"Cytokine."},{"key":"10.1016\/j.autrev.2020.102740_bb0580","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijcard.2019.04.063","article-title":"Circulating cytokines predict severity of rheumatic heart disease","volume":"289","author":"Diamantino Soares","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.autrev.2020.102740_bb0585","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1006\/jaut.2000.0487","article-title":"Heart-directed Autoimmunity: the case of rheumatic fever","volume":"16","author":"Guilherme","year":"2001","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2020.102740_bb0590","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jaut.2005.05.005","article-title":"TNF-alpha G-308A polymorphism is associated with rheumatic fever and correlates with increased TNF-alpha production","volume":"25","author":"Sallakci","year":"2005","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2020.102740_bb0595","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1038\/srep04731","article-title":"Tumor necrosis factor-alpha 308G>A polymorphism and risk of rheumatic heart disease: a meta-analysis","volume":"4","author":"Zheng","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2020.102740_bb0600","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0896-8411(03)00079-9","article-title":"Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with rheumatic heart disease","volume":"21","author":"Hernandez-Pacheco","year":"2003","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2020.102740_bb0605","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00246-006-0002-7","article-title":"Gene Polymorphisms of TNF-\u03b1\u2212308, IL-10\u22121082, IL-6\u2212174, and IL-1RaVNTR related to susceptibility and severity of rheumatic heart disease","volume":"28","author":"Settin","year":"2007","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.autrev.2020.102740_bb0610","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00251-013-0700-2","article-title":"Structure of tumor necrosis factor-alpha haploblocks in European populations","volume":"65","author":"Merino","year":"2013","journal-title":"Immunogenetics."},{"key":"10.1016\/j.autrev.2020.102740_bb0615","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0002-9440(10)63415-3","article-title":"Rheumatic heart disease: proinflammatory cytokines play a role in the progression and maintenance of valvular lesions","volume":"165","author":"Guilherme","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2020.102740_bb0620","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00246-015-1245-y","article-title":"IL10 promoter polymorphisms are associated with rheumatic heart disease in Saudi Arabian patients","volume":"37","author":"Abdallah","year":"2016","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.autrev.2020.102740_bb0625","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1536\/ihj.46.397","article-title":"Lack of association of genetic polymorphisms in the interleukin-1\u03b2, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 genes with risk of rheumatic heart disease in Taiwan Chinese","volume":"46","author":"Chou","year":"2005","journal-title":"Int Heart J"},{"key":"10.1016\/j.autrev.2020.102740_bb0630","doi-asserted-by":"crossref","first-page":"758","DOI":"10.4103\/ijmr.IJMR_1554_14","article-title":"Association of rheumatic fever & rheumatic heart disease with plausible early & late-stage disease markers","volume":"145","author":"Sarkar","year":"2017","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.autrev.2020.102740_bb0635","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.cyto.2016.06.029","article-title":"Association study involving polymorphisms in IL-6, IL-1RA, and CTLA4 genes and rheumatic heart disease in New Zealand population of Maori and Pacific ancestry","volume":"85","author":"Azevedo","year":"2016","journal-title":"Cytokine."},{"key":"10.1016\/j.autrev.2020.102740_bb0640","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cyto.2009.09.003","article-title":"Interleukin-1 receptor antagonist gene (IL1RN) polymorphism possibly associated to severity of rheumatic carditis in a Brazilian cohort","volume":"49","author":"Azevedo","year":"2010","journal-title":"Cytokine."},{"key":"10.1016\/j.autrev.2020.102740_bb0645","author":"Australian Institute of Health and Welfare"},{"key":"10.1016\/j.autrev.2020.102740_bb0650","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1161\/CIRCULATIONAHA.118.033465","article-title":"Rheumatic heart disease in pregnancy","volume":"137","author":"French","year":"2018","journal-title":"Circulation."},{"key":"10.1016\/j.autrev.2020.102740_bb0655","first-page":"1","article-title":"Group A streptococcal diseases and their global burden","volume":"368","author":"Ralph","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.autrev.2020.102740_bb0660","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1440-1754.2002.00772.x","article-title":"Systematic review of rheumatic heart disease prevalence in children in developing countries: the role of environmental factors","volume":"38","author":"Steer","year":"2002","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.autrev.2020.102740_bb0665","unstructured":"Hunt G, Wyatt K. $35 Million for vaccine to end rheumatic heart disease: In: Media release. Commonwealth Government of Australia, https:\/\/parlinfo.aph.gov.au\/parlInfo\/search\/display\/display.w3p;query=Id%3A%22media%2Fpressrel%2F6520148%22;src1=sm1; 2019. [accessed 19 March 2019]."},{"key":"10.1016\/j.autrev.2020.102740_bb0670","doi-asserted-by":"crossref","first-page":"768","DOI":"10.2471\/BLT.13.134486","article-title":"The case for global investment in rheumatic heart-disease control","volume":"92","author":"Wyber","year":"2014","journal-title":"Bull World Health Organ"},{"issue":"3","key":"10.1016\/j.autrev.2020.102740_bb0675","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1080\/17441692.2018.1515970","article-title":"Time to tackle rheumatic heart disease: data needed to drive global policy dialogues","volume":"14","author":"Abouzeid","year":"2019","journal-title":"Glob Public Health"},{"key":"10.1016\/j.autrev.2020.102740_bb0680","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0140-6736(00)88048-4","article-title":"Milroy Lectures on the incidence of rheumatic diseases","volume":"215","author":"Glover","year":"1930","journal-title":"Lancet."},{"key":"10.1016\/j.autrev.2020.102740_bb0685","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMp078039","article-title":"Rheumatic heart disease in developing countries","volume":"357","author":"Carapetis","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2020.102740_bb0690","author":"New Zealand Ministry of Health"},{"key":"10.1016\/j.autrev.2020.102740_bb0695","first-page":"881","article-title":"Acute rheumatic fever in First Nations communities in northwestern Ontario: social determinants of health \u201cbite the heart\u201d","volume":"61","author":"Gordon","year":"2015","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.autrev.2020.102740_bb0700","doi-asserted-by":"crossref","first-page":"102530","DOI":"10.1016\/j.autrev.2020.102530","article-title":"Microbiota and metabolites in rheumatic diseases","volume":"19","author":"Tong","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102740_bb0705","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2471\/BLT.07.043034","article-title":"Disease burden and health-care clinic attendances for young children in remote aboriginal communities of northern Australia","volume":"86","author":"Clucas","year":"2008","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.autrev.2020.102740_bb0710","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/pgmj.2003.014563","article-title":"Scabies: more than just an irritation","volume":"80","author":"McCarthy","year":"2004","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.autrev.2020.102740_bb0715","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002872","article-title":"Scabies mite inactive serine proteases are potent inhibitors of the human complement lectin pathway","volume":"8","author":"Reynolds","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.autrev.2020.102740_bb0720","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1046\/j.1440-0960.2000.00417.x","article-title":"Skin infections and infestations in Aboriginal communities in northern Australia","volume":"41","author":"Currie","year":"2000","journal-title":"Aust J Dermatol"},{"key":"10.1016\/j.autrev.2020.102740_bb0725","article-title":"A regional initiative to reduce skin infections amongst aboriginal children living in remote communities of the Northern Territory","volume":"3","author":"Andrews","year":"2009","journal-title":"Australia PLoS Negl Trop Dis"},{"key":"10.1016\/j.autrev.2020.102740_bb0730","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203684","article-title":"Ascertaining infectious disease burden through primary care clinic attendance among young Aboriginal children living in four remote communities in Western Australia","volume":"13","author":"Hendrickx","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2020.102740_bb0735","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005726","article-title":"Are scabies and impetigo \u201cnormalised\u201d? A cross-sectional comparative study of hospitalised children in northern Australia assessing clinical recognition and treatment of skin infections","volume":"11","author":"Yeoh","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.autrev.2020.102740_bb0740","doi-asserted-by":"crossref","first-page":"37","DOI":"10.5114\/reum.2018.74748","article-title":"Rheumatic fever - new diagnostic criteria","volume":"56","author":"Szczygielska","year":"2018","journal-title":"Reumatologia."},{"key":"10.1016\/j.autrev.2020.102740_bb0745","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1161\/CIR.0000000000000205","article-title":"Revision of the Jones Criteria for the diagnosis of acute rheumatic fever in the era of doppler echocardiography: a scientific statement from the American Heart Association [published correction appears in Circulation. 2020 Jul 28;142:e65]","volume":"131","author":"Gewitz","year":"2015","journal-title":"Circulation."},{"key":"10.1016\/j.autrev.2020.102740_bb0750","author":"Carapetis"},{"key":"10.1016\/j.autrev.2020.102740_bb0755","unstructured":"RHDAustralia (ARF\/RHD writing group). The 2020 Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease. 3rd ed. https:\/\/www.rhdaustralia.org.au\/system\/files\/fileuploads\/arf_rhd_guidelines_3rd_edition_web.pdf 2020. [accessed 19 February 2020]."},{"key":"10.1016\/j.autrev.2020.102740_bb0760","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/heartasia-2016-010847","article-title":"Screening-detected rheumatic heart disease can progress to severe disease","volume":"8","author":"Engelman","year":"2016","journal-title":"Heart Asia"},{"key":"10.1016\/j.autrev.2020.102740_bb0765","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1161\/CIRCULATIONAHA.117.029936","article-title":"Latent rheumatic heart disease: identifying the children at highest risk of unfavorable outcome","volume":"136","author":"Beaton","year":"2017","journal-title":"Circulation."},{"key":"10.1016\/j.autrev.2020.102740_bb0770","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.hlc.2019.02.196","article-title":"Single parasternal-long-axis-view-sweep screening echocardiographic protocol to detect rheumatic heart disease: a prospective study of diagnostic accuracy","volume":"29","author":"Remenyi","year":"2020","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.autrev.2020.102740_bb0775","doi-asserted-by":"crossref","DOI":"10.1097\/01.hjh.0000499973.02423.08","article-title":"OS 01-07 Clinical importance of collagen metabolism markers in rheumatic heart valve disease in Indian subpopulation","volume":"34","author":"Banerjee","year":"2016","journal-title":"J Hypertens"},{"key":"10.1016\/j.autrev.2020.102740_bb0780","first-page":"265","article-title":"Epidemiology of group A streptococcal infections--their changing frequency and severity","volume":"55","author":"Quinn","year":"1982","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.autrev.2020.102740_bb0785","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s40746-015-0013-9","article-title":"The mysteries of streptococcal pharyngitis","volume":"1","author":"Martin","year":"2015","journal-title":"Curr Treat Options Pediatr"},{"key":"10.1016\/j.autrev.2020.102740_bb0790","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.otohns.2007.07.033","article-title":"Systematic review of factors contributing to penicillin treatment failure in Streptococcus pyogenes pharyngitis","volume":"137","author":"Pichichero","year":"2007","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.autrev.2020.102740_bb0795","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.micpath.2011.03.009","article-title":"Biofilm formation or internalization into epithelial cells enable Streptococcus pyogenes to evade antibiotic eradication in patients with pharyngitis","volume":"51","author":"Ogawa","year":"2011","journal-title":"Microb Pathog"},{"key":"10.1016\/j.autrev.2020.102740_bb0800","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0140-6736(18)30999-1","article-title":"Acute rheumatic fever","volume":"392","author":"Karthikeyan","year":"2018","journal-title":"Lancet."},{"key":"10.1016\/j.autrev.2020.102740_bb0805","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0022-3476(94)70247-0","article-title":"Persistence of acute rheumatic fever in the intermountain area of the United States","volume":"124","author":"Veasy","year":"1994","journal-title":"J Pediatr"},{"key":"10.1016\/j.autrev.2020.102740_bb0810","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/archotol.126.11.1359","article-title":"Fewer symptoms occur in same-serotype recurrent streptococcal tonsillopharyngitis","volume":"126","author":"Lee","year":"2000","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.autrev.2020.102740_bb0815","article-title":"Anti-inflammatory treatment for carditis in acute rheumatic fever","volume":"5","author":"Cilliers","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"suppl_1","key":"10.1016\/j.autrev.2020.102740_bb0820","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1093\/cvr\/cvy060.240","article-title":"P325Statin inhibits synthesis of type I collagen in patients with rheumatic heart disease","volume":"114","author":"Herry","year":"2018","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.autrev.2020.102740_bb0825","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/j.hlc.2019.05.136","article-title":"Interventional management of indigenous rheumatic valvular heart disease at TPCH","volume":"28","author":"Hlaing","year":"2019","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.autrev.2020.102740_bb0830","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.hlc.2010.02.019","article-title":"Rheumatic heart disease in Indigenous populations","volume":"19","author":"White","year":"2010","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.autrev.2020.102740_bb0835","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.hlc.2018.05.198","article-title":"Outcomes of redo valve surgery in Indigenous Australians","volume":"28","author":"Keenan","year":"2019","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.autrev.2020.102740_bb0840","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1471-0528.2000.tb11696.x","article-title":"Pregnancy outcomes and cardiac complications in women with mechanical, bioprosthetic and homograft valves","volume":"107","author":"Sadler","year":"2000","journal-title":"BJOG."},{"key":"10.1016\/j.autrev.2020.102740_bb0845","author":"Hill"},{"key":"10.1016\/j.autrev.2020.102740_bb0850","author":"World Health Organisation"},{"key":"10.1016\/j.autrev.2020.102740_bb0855","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004151","article-title":"Impact of an ivermectin mass drug administration on scabies prevalence in a remote Australian Aboriginal community","volume":"9","author":"Kearns","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.autrev.2020.102740_bb0860","first-page":"1464","article-title":"Prophylactic penicillin by the full moon: a novel approach in Central Australia that may help to reduce the risk of rheumatic heart disease","volume":"10","author":"Kearns","year":"2010","journal-title":"Rural Remote Health"},{"key":"10.1016\/j.autrev.2020.102740_bb0865","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1445-5994.2012.02838.x","article-title":"Variability in disease burden and management of rheumatic fever and rheumatic heart disease in two regions of tropical Australia","volume":"43","author":"R\u00e9mond","year":"2013","journal-title":"Intern Med J"},{"key":"10.1016\/j.autrev.2020.102740_bb0870","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13063-016-1166-y","article-title":"Improving delivery of secondary prophylaxis for rheumatic heart disease in remote Indigenous communities: study protocol for a stepped-wedge randomised trial","volume":"17","author":"Ralph","year":"2016","journal-title":"Trials."},{"key":"10.1016\/j.autrev.2020.102740_bb0875","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009308","article-title":"Improving delivery of secondary prophylaxis for rheumatic heart disease in a high-burden setting: outcome of a stepped-wedge, community, randomized trial","volume":"7","author":"Ralph","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.autrev.2020.102740_bb0880","author":"RHDAction"},{"key":"10.1016\/j.autrev.2020.102740_bb0885","doi-asserted-by":"crossref","DOI":"10.5694\/mja15.00139","article-title":"Rheumatic heart disease in Indigenous children in northern Australia: differences in prevalence and the challenges of screening","volume":"203","author":"Roberts","year":"2015","journal-title":"Med J Aust"},{"key":"10.1016\/j.autrev.2020.102740_bb0890","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/1753-6405.12737","article-title":"Aboriginal children and penicillin injections for rheumatic fever: how much of a problem is injection pain?","volume":"42","author":"Mitchell","year":"2018","journal-title":"Aust N Z J Public Health"},{"key":"10.1016\/j.autrev.2020.102740_bb0895","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.gheart.2013.08.011","article-title":"Benzathine Penicillin G for the management of RHD: concerns about quality and access, and opportunities for intervention and improvement","volume":"8","author":"Wyber","year":"2013","journal-title":"Glob Heart"},{"key":"10.1016\/j.autrev.2020.102740_bb0900","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehy763","article-title":"Momentum builds for a global response to rheumatic heart disease","volume":"39","author":"Sliwa","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.autrev.2020.102740_bb0905","author":"RHDAustralia"},{"key":"10.1016\/j.autrev.2020.102740_bb0910","unstructured":"Australian Institute of Health and Welfare. Acute rheumatic fever and rheumatic heart disease in Australia, 2014-2018, https:\/\/www.aihw.gov.au\/reports\/heart-stroke-vascular-diseases\/acute-rheumatic-fever\/contents\/summary; 2019. [accessed 12 May 2019]."},{"key":"10.1016\/j.autrev.2020.102740_bb0915","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/fty016","article-title":"Protein adhesins as vaccine antigens for group A Streptococcus","volume":"76","author":"Raynes","year":"2018","journal-title":"Pathog Dis"},{"key":"10.1016\/j.autrev.2020.102740_bb0920","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/cid\/ciy1143","article-title":"The path to group A Streptococcus vaccines: World Health Organization research and development technology roadmap and preferred product characteristics","volume":"69","author":"Vekemans","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.autrev.2020.102740_bb0925","series-title":"Streptococcus pyogenes: Basic biology to clinical manifestations","article-title":"Current approaches to group A streptococcal vaccine development, in Streptococcus pyogenes","author":"Dale","year":"2016"},{"key":"10.1016\/j.autrev.2020.102740_bb0930","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/vaccines7030058","article-title":"Recent advances in the development of peptide vaccines and their delivery systems against group A Streptococcus","volume":"7","author":"Azuar","year":"2019","journal-title":"Vaccines"},{"key":"10.1016\/j.autrev.2020.102740_bb0935","first-page":"1453","article-title":"The Limitations of the rheumatogenic concept for group A Streptococcus: systematic review and genetic analysis","volume":"7","author":"de Crombrugghe","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.autrev.2020.102740_bb0940","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1084\/jem.110.2.271","article-title":"Persistence of type-specific antibodies in man following infection with group A Streptococci","volume":"110","author":"Lancefield","year":"1959","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2020.102740_bb0945","doi-asserted-by":"crossref","first-page":"307","DOI":"10.4049\/jimmunol.89.3.307","article-title":"Current knowledge of type-specific M antigens of group A Streptococci","volume":"89","author":"Lancefield","year":"1962","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2020.102740_bb0950","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.vaccine.2013.01.019","article-title":"Potential coverage of a multivalent M protein-based group A streptococcal vaccine","volume":"31","author":"Dale","year":"2013","journal-title":"Vaccine."},{"key":"10.1016\/j.autrev.2020.102740_bb0955","doi-asserted-by":"crossref","first-page":"B216","DOI":"10.1016\/j.vaccine.2012.09.045","article-title":"Group A streptococcal vaccines: paving a path for accelerated development","volume":"31","author":"Dale","year":"2013","journal-title":"Vaccine."},{"key":"10.1016\/j.autrev.2020.102740_bb0960","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/jama.292.6.709","article-title":"Safety and immunogenicity of a recombinant multivalent group A streptococcal vaccine in healthy adults: phase 1 trial","volume":"292","author":"Kotloff","year":"2004","journal-title":"JAMA."},{"key":"10.1016\/j.autrev.2020.102740_bb0965","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ics.2005.12.002","article-title":"A double-blind, randomized phase II trial of the safety and immunogenicity of 26-valent group A Streptococcus vaccine in healthy adults","volume":"1289","author":"McNeil","year":"2006","journal-title":"Int Congr Ser"},{"key":"10.1016\/j.autrev.2020.102740_bb0970","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1016\/j.vaccine.2016.03.073","article-title":"Status of research and development of vaccines for Streptococcus pyogenes","volume":"34","author":"Steer","year":"2016","journal-title":"Vaccine."},{"key":"10.1016\/j.autrev.2020.102740_bb0975","doi-asserted-by":"crossref","first-page":"8175","DOI":"10.1016\/j.vaccine.2011.09.005","article-title":"New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A Streptococci","volume":"29","author":"Dale","year":"2011","journal-title":"Vaccine."},{"key":"10.1016\/j.autrev.2020.102740_bb0980","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007511","article-title":"Concerns for efficacy of a 30-valent M-protein-based Streptococcus pyogenes vaccine in regions with high rates of rheumatic heart disease","volume":"13","author":"Giffard","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.autrev.2020.102740_bb0985","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.vaccine.2019.12.005","article-title":"Safety and immunogenicity of a 30-valent M protein-based group A streptococcal vaccine in healthy adult volunteers: a randomized, controlled phase I study","volume":"38","author":"Pastural","year":"2020","journal-title":"Vaccine."},{"key":"10.1016\/j.autrev.2020.102740_bb0990","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.1016\/j.vaccine.2010.05.046","article-title":"Diversity of emm sequence types in group A beta-haemolytic Streptococci in two remote Northern Territory Indigenous communities: implications for vaccine development","volume":"28","author":"Richardson","year":"2010","journal-title":"Vaccine."},{"key":"10.1016\/j.autrev.2020.102740_bb0995","doi-asserted-by":"crossref","first-page":"703","DOI":"10.4269\/ajtmh.2011.11-0185","article-title":"Acute post-streptococcal glomerulonephritis in the Northern Territory of Australia: a review of 16 years data and comparison with the literature","volume":"85","author":"Marshall","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.autrev.2020.102740_bb1000","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.4161\/hv.25506","article-title":"Strategies in the development of vaccines to prevent infections with group A Streptococcus","volume":"9","author":"Good","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.autrev.2020.102740_bb1005","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/intimm\/9.11.1723","article-title":"Mapping the minimal murine T cell and B cell epitopes within a peptide vaccine candidate from the conserved region of the M protein of group A Streptococcus","volume":"9","author":"Hayman","year":"1997","journal-title":"Int Immunol"},{"key":"10.1016\/j.autrev.2020.102740_bb1010","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/S0264-410X(97)00178-3","article-title":"Human antibodies to the conserved region of the M protein: opsonization of heterologous strains of group A Streptococci","volume":"15","author":"Brandt","year":"1997","journal-title":"Vaccine."},{"key":"10.1016\/j.autrev.2020.102740_bb1015","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1001\/jama.1969.03150190037007","article-title":"Rheumatic fever following streptococcal vaccination: report of three cases","volume":"207","author":"Massell","year":"1969","journal-title":"JAMA."},{"key":"10.1016\/j.autrev.2020.102740_bb1020","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/infdis\/131.3.217","article-title":"Protective studies with a group A streptococcal M protein vaccine. II. Challange of volunteers after local immunization in the upper respiratory tract","volume":"131","author":"Polly","year":"1975","journal-title":"J Infect Dis"},{"key":"10.1016\/j.autrev.2020.102740_bb1025","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1172\/JCI107372","article-title":"Protective study with a group A streptococcal M protein vaccine. infectivity challenge of human volunteers","volume":"52","author":"Fox","year":"1973","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2020.102740_bb1030","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/infdis\/138.6.712","article-title":"Protective studies with group A streptococcal M protein vaccine. III. Challenge of volunteers after systemic or intranasal immunization with Type 3 or Type 12 group A Streptococcus","volume":"138","author":"D\u2019Alessandri","year":"1978","journal-title":"J Infect Dis"},{"key":"10.1016\/j.autrev.2020.102740_bb1035","first-page":"72197","article-title":"HHS. Revocation of status of specific products; Group A streptococcus","volume":"70","author":"Food and Drug Administration","year":"2005","journal-title":"Direct final rule Fed Regist"},{"key":"10.1016\/j.autrev.2020.102740_bb1040","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ics.2005.12.004","article-title":"Molecular mimicry, autoimmunity and infection in the pathogenesis of rheumatic fever","volume":"1289","author":"Cunningham","year":"2006","journal-title":"Int Congr Ser"},{"key":"10.1016\/j.autrev.2020.102740_bb1045","doi-asserted-by":"crossref","first-page":"5345","DOI":"10.1128\/IAI.69.9.5345-5351.2001","article-title":"T-cell reactivity against streptococcal antigens in the periphery mirrors reactivity of heart-infiltrating T lymphocytes in rheumatic heart disease patients","volume":"69","author":"Guilherme","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.autrev.2020.102740_bb1050","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s12265-013-9526-4","article-title":"Identification of streptococcal M-protein cardiopathogenic epitopes in experimental autoimmune valvulitis","volume":"7","author":"Kirvan","year":"2014","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.autrev.2020.102740_bb1055","first-page":"12","article-title":"Mapping a conserved conformational epitope from the M protein of group A Streptococci","volume":"9","author":"Relf","year":"1996","journal-title":"Pept Res"},{"key":"10.1016\/j.autrev.2020.102740_bb1060","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1586\/14760584.2015.1081817","article-title":"Strategic development of the conserved region of the M protein and other candidates as vaccines to prevent infection with group A Streptococci","volume":"14","author":"Good","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.autrev.2020.102740_bb1065","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.4049\/jimmunol.1700836","article-title":"Enhancing vaccine efficacy by engineering a complex synthetic peptide to become a super immunogen","volume":"199","author":"Nordstr\u00f6m","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2020.102740_bb1070","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1586\/14760584.2016.1154791","article-title":"Cryptic epitope for antibodies should not be forgotten in vaccine design","volume":"15","author":"Good","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.autrev.2020.102740_bb1075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156639","article-title":"Predicted coverage and immuno-safety of a recombinant C-repeat region based Streptococcus pyogenes vaccine candidate","volume":"11","author":"McNeilly","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2020.102740_bb1080","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1086\/374800","article-title":"Protection against group A Streptococcus by immunization with J8-Diphtheria toxoid: contribution of J8- and Diphtheria toxoid-Specific antibodies to protection","volume":"187","author":"Batzloff","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.autrev.2020.102740_bb1085","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1086\/505146","article-title":"Intranasal vaccination with a lipopeptide containing a conformationally constrained conserved minimal peptide, a universal T cell epitope, and a self-adjuvanting lipid protects mice from group A Streptococcus challenge and reduces throat colonization","volume":"194","author":"Batzloff","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.autrev.2020.102740_bb1090","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/74719","article-title":"New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population","volume":"6","author":"Brandt","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2020.102740_bb1095","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.nano.2010.10.002","article-title":"Self-adjuvanting polyacrylic nanoparticulate delivery system for group A streptococcus (GAS) vaccine","volume":"7","author":"Zaman","year":"2011","journal-title":"Nanomedicine."},{"key":"10.1016\/j.autrev.2020.102740_bb1100","doi-asserted-by":"crossref","first-page":"13786","DOI":"10.1038\/s41598-017-14157-7","article-title":"Physicochemical characterisation, immunogenicity and protective efficacy of a lead streptococcal vaccine: progress towards Phase I trial","volume":"7","author":"Pandey","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2020.102740_bb1105","doi-asserted-by":"crossref","first-page":"39274","DOI":"10.1038\/srep39274","article-title":"Novel platform technology for modular mucosal vaccine that protects against streptococcus","volume":"6","author":"Zaman","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2020.102740_bb1110","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3389\/fped.2014.00116","article-title":"Animal models to investigate the pathogenesis of rheumatic heart disease","volume":"2","author":"Rush","year":"2014","journal-title":"Front Pediatr"},{"key":"10.1016\/j.autrev.2020.102740_bb1115","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jim.2010.02.013","article-title":"An alternative technique for the induction of autoimmune valvulitis in a rat model of rheumatic heart disease","volume":"355","author":"Gorton","year":"2010","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.autrev.2020.102740_bb1120","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1086\/466528","article-title":"Toward the development of an antidisease, transmission-blocking intranasal vaccine for group A Streptococcus","volume":"192","author":"Batzloff","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.autrev.2020.102740_bb1125","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1128\/IAI.69.6.4072-4078.2001","article-title":"Induction of autoimmune valvular heart disease by recombinant streptococcal M protein","volume":"69","author":"Quinn","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.autrev.2020.102740_bb1130","doi-asserted-by":"crossref","first-page":"5915","DOI":"10.4049\/jimmunol.1500157","article-title":"A synthetic M protein peptide synergizes with a CXC chemokine protease to induce vaccine-mediated protection against virulent streptococcal pyoderma and bacteremia","volume":"194","author":"Pandey","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2020.102740_bb1135","author":"Telethon Kids Institute"},{"key":"10.1016\/j.autrev.2020.102740_bb1140","author":"World Heart Federation"},{"key":"10.1016\/j.autrev.2020.102740_bb1145","series-title":"RHD Action. United to end rheumatic heart disease","author":"RHDAction","year":"2019"},{"key":"10.1016\/j.autrev.2020.102740_bb1150","article-title":"What constitutes a neglected tropical disease?","volume":"14","author":"Hotez","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.autrev.2020.102740_bb1155","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.4049\/jimmunol.1202333","article-title":"Long-term antibody memory induced by synthetic peptide vaccination is protective against Streptococcus pyogenes infection and is independent of memory T cell help","volume":"190","author":"Pandey","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2020.102740_bb1160","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1080\/21645515.2016.1222999","article-title":"Preclinical immunogenicity and safety of a group A streptococcal M protein-based vaccine candidate","volume":"12","author":"Batzloff","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.autrev.2020.102740_bb1165","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41541-018-0053-9","article-title":"Skin infection boosts memory B-cells specific for a cryptic vaccine epitope of group A Streptococcus and broadens the immune response to enhance vaccine efficacy","volume":"3","author":"Pandey","year":"2018","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.autrev.2020.102740_bb1170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198658","article-title":"Evaluation of safety and immunogenicity of a group A Streptococcus vaccine candidate (MJ8VAX) in a randomized clinical trial","volume":"13","author":"Sekuloski","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2020.102740_bb1175","doi-asserted-by":"crossref","first-page":"eaax3013","DOI":"10.1126\/sciadv.aax3013","article-title":"Antibodies to the conserved region of the M protein and a streptococcal superantigen cooperatively resolve toxic shock-like syndrome in HLA-humanized mice","volume":"5","author":"Pandey","year":"2019","journal-title":"Sci Adv"},{"key":"10.1016\/j.autrev.2020.102740_bb1180","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1172\/JCI5118","article-title":"New protective antigen of group A Streptococci","volume":"103","author":"Dale","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2020.102740_bb1185","first-page":"125","article-title":"Freschi de Barros S, et al. Towards a vaccine against rheumatic fever","volume":"13","author":"Guilherme","year":"2006","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.autrev.2020.102740_bb1190","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.vaccine.2016.11.065","article-title":"Structure-based design of broadly protective group a streptococcal M protein-based vaccines","volume":"35","author":"Dale","year":"2017","journal-title":"Vaccine."},{"key":"10.1016\/j.autrev.2020.102740_bb1195","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.4049\/jimmunol.1501994","article-title":"Combinatorial synthetic peptide vaccine strategy protects against hypervirulent CovR\/S mutant Streptococci","volume":"196","author":"Pandey","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2020.102740_bb1200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.0020005","article-title":"Genome-wide analysis of group A Streptococci reveals a mutation that modulates global phenotype and disease specificity","volume":"2","author":"Sumby","year":"2006","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.autrev.2020.102740_bb1205","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fcimb.2018.00160","article-title":"Group A Streptococcus M1T1 intracellular infection of primary tonsil epithelial cells dampens levels of secreted IL-8 through the action of SpyCEP","volume":"8","author":"Soderholm","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.autrev.2020.102740_bb1210","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1542\/peds.101.4.604","article-title":"Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants","volume":"101","author":"Rennels","year":"1998","journal-title":"Pediatrics."},{"key":"10.1016\/j.autrev.2020.102740_bb1215","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1016\/j.vaccine.2019.03.059","article-title":"Controlled human infection for vaccination against Streptococcus pyogenes (CHIVAS): establishing a group A Streptococcus pharyngitis human infection study","volume":"37","author":"Osowicki","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.autrev.2020.102740_bb1220","author":"ClinicalTrials.gov"},{"key":"10.1016\/j.autrev.2020.102740_bb1225","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1086\/444458","article-title":"Safety and immunogenicity of 26-valent group A Streptococcus vaccine in healthy adult volunteers","volume":"41","author":"McNeil","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.autrev.2020.102740_bb1230","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1128\/IAI.73.4.2360-2366.2005","article-title":"Clinical and microbiological responses of volunteers to combined intranasal and oral inoculation with a Streptococcus gordonii carrier strain intended for future use as a group A Streptococcus vaccine","volume":"73","author":"Kotloff","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.autrev.2020.102740_bb1235","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/j.vaccine.2013.02.013","article-title":"Self-adjuvanting modular virus-like particles for mucosal vaccination against group A Streptococcus (GAS)","volume":"31","author":"Rivera-Hernandez","year":"2013","journal-title":"Vaccine."},{"key":"10.1016\/j.autrev.2020.102740_bb1240","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/vaccines8010023","article-title":"Polyacrylate-peptide antigen conjugate as a single-dose oral vaccine against group A Streptococcus","volume":"8","author":"Faruck","year":"2020","journal-title":"Vaccines."},{"key":"10.1016\/j.autrev.2020.102740_bb1245","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.vaccine.2011.12.115","article-title":"Evaluation of novel Streptococcus pyogenes vaccine candidates incorporating multiple conserved sequences from the C-repeat region of the M-protein","volume":"30","author":"Bauer","year":"2012","journal-title":"Vaccine."},{"key":"10.1016\/j.autrev.2020.102740_bb1250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060969","article-title":"StreptInCor: a candidate vaccine epitope against S. pyogenes infections induces protection in outbred mice","volume":"8","author":"Postol","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2020.102740_bb1255","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ymeth.2009.03.024","article-title":"A vaccine against S. pyogenes: design and experimental immune response","volume":"49","author":"Guilherme","year":"2009","journal-title":"Methods."},{"key":"10.1016\/j.autrev.2020.102740_bb1260","doi-asserted-by":"crossref","first-page":"9733","DOI":"10.1038\/s41598-019-46244-2","article-title":"Group A Streptococcus adsorbed vaccine: repeated intramuscular dose toxicity test in minipigs","volume":"9","author":"Postol","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2020.102740_bb1265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174464","article-title":"Immunization with a streptococcal multiple-epitope recombinant protein protects mice against invasive group A streptococcal infection","volume":"12","author":"Kuo","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2020.102740_bb1270","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1086\/377700","article-title":"Immune response to group A streptococcal C5a peptidase in children: implications for vaccine development","volume":"188","author":"Shet","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.autrev.2020.102740_bb1275","doi-asserted-by":"crossref","first-page":"7878","DOI":"10.1128\/IAI.73.12.7878-7886.2005","article-title":"Active and passive intranasal immunizations with streptococcal surface protein C5a peptidase prevent infection of murine nasal mucosa-associated lymphoid tissue, a functional homologue of human tonsils","volume":"73","author":"Park","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.autrev.2020.102740_bb1280","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1128\/IAI.69.2.924-930.2001","article-title":"Systemic and mucosal immunizations with fibronectin-binding protein FBP54 induce protective immune responses against Streptococcus pyogenes challenge in mice","volume":"69","author":"Kawabata","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.autrev.2020.102740_bb1285","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.4049\/jimmunol.152.9.4375","article-title":"Immunological mimicry between N-acetyl-beta-D-glucosamine and cytokeratin peptides. Evidence for a microbially driven anti-keratin antibody response","volume":"152","author":"Shikhman","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2020.102740_bb1290","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1086\/498618","article-title":"Group A Streptococcus (GAS) carbohydrate as an immunogen for protection against GAS infection","volume":"193","author":"Sabharwal","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.autrev.2020.102740_bb1295","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1016\/j.vaccine.2014.04.092","article-title":"Development of a recombinant fusion protein vaccine formulation to protect against Streptococcus pyogenes","volume":"32","author":"Morefield","year":"2014","journal-title":"Vaccine."},{"key":"10.1016\/j.autrev.2020.102740_bb1300","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1515\/BC.2011.208","article-title":"Cysteine proteinase SpeB from Streptococcus pyogenes - a potent modifier of immunologically important host and bacterial proteins","volume":"392","author":"Nelson","year":"2011","journal-title":"Biol Chem"},{"key":"10.1016\/j.autrev.2020.102740_bb1305","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/00024382-199712000-00010","article-title":"Streptococcal pyrogenic exotoxins A (SpeA) and C (SpeC) stimulate the production of inducible nitric oxide synthase (iNOS) protein in RAW 264.7 macrophages","volume":"8","author":"Christ","year":"1997","journal-title":"Shock."},{"key":"10.1016\/j.autrev.2020.102740_bb1310","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1208\/s12248-017-0069-5","article-title":"Evaluation of the potency, neutralizing antibody response, and stability of a recombinant fusion protein vaccine for Streptococcus pyogenes","volume":"19","author":"Burlet","year":"2017","journal-title":"AAPS J"},{"key":"10.1016\/j.autrev.2020.102740_bb1315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-07602-0","article-title":"Mucosal vaccination with pili from group A Streptococcus expressed on Lactococcus lactis generates protective immune responses","volume":"7","author":"Loh","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2020.102740_bb1320","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00122-20","article-title":"Vaccine-induced Th1-type response protects against invasive group A Streptococcus infection in the absence of opsonizing antibodies","volume":"11","author":"Rivera-Hernandez","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.autrev.2020.102740_bb1325","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00693-19","article-title":"An experimental group A Streptococcus vaccine that reduces pharyngitis and tonsillitis in a nonhuman primate model","volume":"10","author":"Rivera-Hernandez","year":"2019","journal-title":"mBio."},{"key":"10.1016\/j.autrev.2020.102740_bb1330","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1128\/IAI.01706-14","article-title":"Structural conservation, variability, and immunogenicity of the T6 backbone pilin of serotype M6 Streptococcus pyogenes","volume":"82","author":"Young","year":"2014","journal-title":"Infect Immun"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997220303219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997220303219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:20:26Z","timestamp":1761600026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997220303219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":266,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S1568997220303219"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102740","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rheumatic heart disease: A review of the current status of global research activity","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102740","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102740"}}